These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9441368)

  • 1. Proceedings of the International Society for Oncodevelopmental Biology and Medicine (ISOBM) TD-4 International Workshop on Monoclonal Antibodies against MUC1. San Diego, California, November 17-23, 1996.
    Tumour Biol; 1998; 19 Suppl 1():1-152. PubMed ID: 9441368
    [No Abstract]   [Full Text] [Related]  

  • 2. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
    Price MR; Rye PD; Petrakou E; Murray A; Brady K; Imai S; Haga S; Kiyozuka Y; Schol D; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Kenemans P; Blockzjil A; Nilsson K; Nilsson O; Reddish M; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker MB; Hilgers J
    Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin.
    Dai J; Allard WJ; Davis G; Yeung KK
    Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma-associated MUC1 detected by immunoradiometric assays.
    Norum LF; Varaas T; Kierulf B; Nustad K
    Tumour Biol; 1998; 19 Suppl 1():134-46. PubMed ID: 9422099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the carbohydrate specificity of ISOBM TD-4 Workshop anti-MUC1 antibodies.
    Lloyd KO; Kudryashov V
    Tumour Biol; 1998; 19 Suppl 1():118-21. PubMed ID: 9422096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against the nonmucin domain of MUC1/episialin.
    Hilkens J; Boer M
    Tumour Biol; 1998; 19 Suppl 1():67-70. PubMed ID: 9422090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope characterization of MUC1 antibodies.
    Blockzjil A; Nilsson K; Nilsson O
    Tumour Biol; 1998; 19 Suppl 1():46-56. PubMed ID: 9422088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of carbohydrate specificity of monoclonal antibodies against MUC1.
    Galanina OE; Simeoni LA; Ter-Grigoryan AG; Belyanchikov IM; Bovin NV
    Tumour Biol; 1998; 19 Suppl 1():79-87. PubMed ID: 9422092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity clusters of MUC1-reactive mouse monoclonal antibodies.
    Hanisch FG
    Tumour Biol; 1998; 19 Suppl 1():111-7. PubMed ID: 9422095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine.
    Nustad K; Bast RC; Brien TJ; Nilsson O; Seguin P; Suresh MR; Saga T; Nozawa S; Børmer OP; de Bruijn HW; Nap M; Vitali A; Gadnell M; Clark J; Shigemasa K; Karlsson B; Kreutz FT; Jette D; Sakahara H; Endo K; Paus E; Warren D; Hammarström S; Kenemans P; Hilgers J
    Tumour Biol; 1996; 17(4):196-219. PubMed ID: 8685601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope characterization of MUC1 antibodies.
    Imai S; Haga S; Kiyozuka Y
    Tumour Biol; 1998; 19 Suppl 1():30-4. PubMed ID: 9422086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity of antibodies to MUC1 antigens.
    Karanikas V; Patton K; Jamieson G; Pietersz G; McKenzie I
    Tumour Biol; 1998; 19 Suppl 1():71-8. PubMed ID: 9422091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytes.
    Ciborowski P; Konitzki WM; Blander JM; Finn OJ
    Tumour Biol; 1998; 19 Suppl 1():147-51. PubMed ID: 9422100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of antibodies with highly glycosylated MUC1 mucins from colon carcinoma cells and bile.
    Sikut R; Sikut A; Zhang K; Baeckström D; Hansson GC
    Tumour Biol; 1998; 19 Suppl 1():122-6. PubMed ID: 9422097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1.
    Reis CA; Hassan H; Bennett EP; Clausen H
    Tumour Biol; 1998; 19 Suppl 1():127-33. PubMed ID: 9422098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical characterization of a panel of 56 antibodies with normal human small intestine, colon, and breast tissues.
    Cao Y; Karsten U; Hilgers J
    Tumour Biol; 1998; 19 Suppl 1():88-99. PubMed ID: 9422093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997.
    Rye PD; Bovin NV; Vlasova EV; Molodyk AA; Baryshnikov A; Kreutz FT; Garinther WI; Schultes BC; Noujaim AA; Madiyalakan R; Magnani J; Nilsson O; Nilsson K; Nustad K; Norum L; Bell H; Cao Y; Suresh MR; Very DL; Freeman JV; Yeung KK; Hilgers J
    Tumour Biol; 1998; 19(5):390-420. PubMed ID: 9701730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen.
    Movahedin M; Brooks TM; Supekar NT; Gokanapudi N; Boons GJ; Brooks CL
    Glycobiology; 2017 Jul; 27(7):677-687. PubMed ID: 28025250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy.
    Madsen CB; Wandall HH; Pedersen AE
    Immunopharmacol Immunotoxicol; 2013 Dec; 35(6):649-52. PubMed ID: 24063621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
    Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
    Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.